Episode 288: APCCC #3: Controversies around Radiotherapy

Episode 288: APCCC #3: Controversies around R...

THE UROMIGOSTHE UROMIGOS

Up next

Episodio 485: ASCO GU 2026 - LITESPARK 011: Len/Belzutifan vs Cabo

En este episodio se abordan los resultados más recientes del ensayo fase 3 LITESPARK 011 (belzutifan + lenvatinib frente a cabozantinib). Brian, Tom y Bob Motzer analizan la eficacia, seguridad y las implicaciones de los resultados para la secuenciación de tratamiento. 

 . 31min 27sec
Episodio 484: ASCO GU 2026 - LITESPARK 022: Pembro adyuvante + Belzutifan en cáncer renal 

En esta discusión se exploran los últimos avances en el tratamiento adyuvante del cáncer de riñón, centrándose en los recientes resultados del ensayo fase 3 de belzutifan en combinación con pembrolizumab (LITESPARK-022). Se abordan los pormenores del mecanismo de acción, el desar ...  Show more

 . 36min 53sec

Recommended Episodes

Episode 087: Prostate Cancer Series: Pt. 4- Radiation Oncology in Prostate Cancer
The Fellow on Call: The Heme/Onc Podcast

Last, but not least, in our multidisciplinary discussions regarding the management of prostate cancer, we are thrilled to present a special episode featuring soon-to-be attending Radiation Oncologist Dr. Jacob Hall. Dr. Hall is a senior R ...

  Show more

 . 41min 0sec
Metastatic Prostate Cancer
Two Onc Docs

Today’s episode is part 2 of our prostate cancer series, and will focus on the important details regarding treatment options for castrate sensitive and resistant prostate cancer.

 

 . 13min 13sec
Beating Prostate Cancer
Nutrition Facts with Dr. Greger

New research on prostate cancer screening and diet 

 . 15min 32sec
Localized Prostate Cancer
Two Onc Docs

This is the first of a two part episode on prostate cancer. This episode will cover localized prostate cancer, including the diagnostic work-up, staging and treatment. 

 

 . 12min 54sec